More
    Guided Solutions - Connecting Talent With Innovation/div>

    4DMedical secures $150M backing from institutional investors

    Melbourne-based respiratory imaging company 4DMedical has raised $150 million from institutional investors to accelerate commercialisation of its key CT:VQ product in the US where...

    Distalmotion secures funding to support Dexter rollout in ASCs

    Distalmotion announced that it secured a strategic investment from Johnson & Johnson’s JJDC venture capital arm. The investment, for which the company did not disclose...

    Inquis Medical announces $75M Series C financing to scale AVENTUS

    Inquis Medical, a privately held medical technology company dedicated to advancing mechanical thrombectomy for venous thromboembolic disease (“VTE”), announced the closing of a $75...

    ViCentra adds $13M in second close of Series D funding round

    ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing commercialisation efforts for its...

    BrightHeart raises €11M Series A to scale AI platform for prenatal ultrasound

    BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, announced the closing of an €11 million Series A financing round. The...

    FineHeart secures additional €35M to support its growth

    FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announced the completion of a €35 million first closing...

    Spiro Medical raises $67M Series A to support neuromod tech

    Spiro Medical announced that it closed a $67 million Series A equity financing to support its neuromodulation system. Irvine, California-based Spiro develops a first-of-its-kind pulmonary...

    Surgerii Robotics raises $100M to take single-port surgical robotics system global

    Surgerii Robotics has closed $100 million in Series D financing. The Beijing-based company said last month that it will use the funding to market its...

    Biobeat secures $50M Series B financing

    Biobeat Technologies, developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment...

    Latest articles